TY - JOUR
T1 - Spray-dried plasma deficient in high-molecular-weight multimers of von Willebrand factor retains hemostatic properties
AU - Meledeo, Michael Adam
AU - Liu, Qiyong Peter
AU - Peltier, Grantham C.
AU - Carney, Ryan C.
AU - McIntosh, Colby S.
AU - Taylor, Ashley S.
AU - Bynum, James A.
AU - Pusateri, Anthony E.
AU - Cap, Andrew P.
N1 - Publisher Copyright:
© 2018 AABB
PY - 2019/2
Y1 - 2019/2
N2 - BACKGROUND: Dried plasmas can overcome logistical barriers that prevent fresh frozen plasma (FFP) usage in acute resuscitation, but processing of these products can detrimentally alter the composition. Spray-dried plasma (SpDP) from single units is deficient in high-molecular-weight multimers of von Willebrand factor (vWF), a critical facilitator of platelet adhesion and thrombus formation. We hypothesized that converting high-molecular-weight multimers to smaller-molecular-weight multimers would retain vWF's capacity to mediate platelet adhesion. STUDY DESIGN AND METHODS: SpDP obtained from untreated FFP was reconstituted with glycine-hydrochloric acid (HCl) and glycine (20 mM:50 mM) or pretreated with glycine-HCl (20 mM) or glycine–glycine-HCl (20 mM:50 mM) and reconstituted with water. In vitro hemostatic potential of SpDPs versus FFP or FFP spiked with 70 mM of glycine was evaluated, leading to a more detailed in vitro study of glycine-HCl–glycine (20 mM:50 mM) pretreated SpDP. Plasmas were combined with RBCs and platelets to observe global coagulation response. RESULTS: While vWF–ristocetin cofactor activity is significantly decreased (−41.13%; p <.0001) in SpDP, a model of vWF-mediated platelet adhesion to collagen under flow showed enhanced function (+13%; p <.01). Fewer microparticles, particularly of platelet origin, were observed in SpDP versus FFP (p <.0001). Small but significant differences in thromboelastography results were observed, although SpDP and FFP were within normal ranges. CONCLUSION: Comparable coagulability was observed in FFP and SpDP. The apparent paradox between vWF–ristocetin cofactor assay and vWF-mediated platelet adhesion may be explained by the increase in smaller multimers of vWF in SpDP, producing different outcomes in these assays.
AB - BACKGROUND: Dried plasmas can overcome logistical barriers that prevent fresh frozen plasma (FFP) usage in acute resuscitation, but processing of these products can detrimentally alter the composition. Spray-dried plasma (SpDP) from single units is deficient in high-molecular-weight multimers of von Willebrand factor (vWF), a critical facilitator of platelet adhesion and thrombus formation. We hypothesized that converting high-molecular-weight multimers to smaller-molecular-weight multimers would retain vWF's capacity to mediate platelet adhesion. STUDY DESIGN AND METHODS: SpDP obtained from untreated FFP was reconstituted with glycine-hydrochloric acid (HCl) and glycine (20 mM:50 mM) or pretreated with glycine-HCl (20 mM) or glycine–glycine-HCl (20 mM:50 mM) and reconstituted with water. In vitro hemostatic potential of SpDPs versus FFP or FFP spiked with 70 mM of glycine was evaluated, leading to a more detailed in vitro study of glycine-HCl–glycine (20 mM:50 mM) pretreated SpDP. Plasmas were combined with RBCs and platelets to observe global coagulation response. RESULTS: While vWF–ristocetin cofactor activity is significantly decreased (−41.13%; p <.0001) in SpDP, a model of vWF-mediated platelet adhesion to collagen under flow showed enhanced function (+13%; p <.01). Fewer microparticles, particularly of platelet origin, were observed in SpDP versus FFP (p <.0001). Small but significant differences in thromboelastography results were observed, although SpDP and FFP were within normal ranges. CONCLUSION: Comparable coagulability was observed in FFP and SpDP. The apparent paradox between vWF–ristocetin cofactor assay and vWF-mediated platelet adhesion may be explained by the increase in smaller multimers of vWF in SpDP, producing different outcomes in these assays.
UR - http://www.scopus.com/inward/record.url?scp=85056769790&partnerID=8YFLogxK
U2 - 10.1111/trf.15038
DO - 10.1111/trf.15038
M3 - Article
C2 - 30450617
AN - SCOPUS:85056769790
SN - 0041-1132
VL - 59
SP - 714
EP - 722
JO - Transfusion
JF - Transfusion
IS - 2
ER -